To obtain access to any datasets listed on this site, you must first receive approval from NIDA Datashare's Data Access Committee (DAC).

Please submit your request by sending your request to NIDA_Datashare_DAC@mail.nih.gov along with the following information:

Your name, title, and organization
Study Number and Study Title
The specific dataset(s) you are requesting
The intended use or purpose of the data
Willingness to comply with the NIDA Datashare Registration Agreement

Once your request is reviewed, you will receive instructions on how to proceed.

Thank you for your cooperation.

NIDA-MDS-0004

Division

DTMC

HEAL Study

Investigator(s)

Domenic Ciraulo, M.D.

Title

Phase 2, Double-Blind, Placebo-Controlled Trial Of Modafinil For The Treatment Of Cocaine Dependence

Short Description

To evaluate the efficacy and safety of modafinil relative to placebo in reducing cocaine use in subjects with cocaine dependence as assessed by self-report confirmed with urine assays for benzoylecgonine (BE).

Release Date

Sep 02, 2015

Description

The primary objective of this study is to evaluate the efficacy of modafinil relative to placebo in increasing the weekly mean proportion of cocaine non-use days over the treatment period as determined by self-report of cocaine use confirmed with urine assays for BE.

Keywords

Assessments

Addiction Severity Index Lite

Brief Substance Craving Scale

Clinical Global Impression Scales

Cocaine Craving Questionnaire - Now

Cocaine Selective Severity Assessment

HIV Risk-Taking Behaviour Scale